This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignee: Keio University. Active years: 2016-2025.
Company Filing History:
Years Active: 2016-2025
Title: The Innovative Contributions of Inventor Shin Hatou
Introduction
Shin Hatou is a prominent inventor based in Tokyo, Japan. He has made significant strides in the fields of medical technology, particularly in the realm of ocular health. With a total of three patents to his name, Hatou continues to push the boundaries of innovation geared toward improving therapeutic methods in corneal transplant procedures.
Latest Patents
The latest patents developed by Shin Hatou highlight his commitment to advancing medical science. His patents include:
1. **Rapid Tumorigenicity Screening System** - This invention provides a novel method for evaluating the tumorigenicity of test cells. By transplanting these cells into the anterior chamber of an experimental animal's eye, researchers can conveniently and efficiently observe tumor formation within a short timeframe.
2. **Method for Producing Therapeutic Corneal Endothelial Substitute Cell Sphere** - This patent addresses the challenge of producing therapeutic alternative corneal endothelial cells. It outlines a process for generating these cells in a stable and scalable manner suitable for intraocular transplantation. The invention also highlights the use of a viscoelastic substance during transplantation to enhance cell adherence post-surgery.
Career Highlights
Shin Hatou works at Keio University, a prestigious institution known for its emphasis on research and innovation in medical sciences. His contributions within this academic environment reflect his dedication to improving human health through cutting-edge technology. Hatou's body of work not only advances scientific understanding but also provides practical solutions to pressing medical challenges.
Collaborations
Collaboration is a key aspect of Hatou's research endeavors. He has worked alongside respected colleagues, including Shigeto Shimmura and Kazuo Tsubota. Together, they contribute to the multidisciplinary approach necessary for advancing therapeutic techniques and improving patient outcomes in ocular health.
Conclusion
In conclusion, Shin Hatou stands out as a visionary inventor, committed to revolutionizing the field of ocular therapeutics. His impactful patents demonstrate a dedication to developing innovative solutions that promise to enhance treatment efficacy for corneal-related conditions. As he continues his work at Keio University, the potential for future innovations remains promising.